Biomedica Medizinprodukte sales and marketing update

Biomedica launched its FGF23 (C-terminal) Elisa assay in Europe to measure intact and C-terminal fragments of fibroblast growth factor 23 (FGF23) levels in serum or plasma samples to predict the pro...